To provide more insight into the role of the endogenous interferon-beta system in the severity of inflammatory disease activity in MS, it is of interest to investigate if this association between homeostatic MxA mRNA levels and clinical and radiological disease activity in MS is still present in the long-term. This evidence concerns the gene IFNB1 and myeloid sarcoma.